SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2024-06-05 11:03
Tx date 2024-06-04 		$FUSN
Fusion Pharmaceuticals Inc. 		Crowley, John Joseph
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Units
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
-63,700 vol 		0
Filed 2024-06-05 11:03
Tx date 2024-06-04 		$FUSN
Fusion Pharmaceuticals Inc. 		Crowley, John Joseph
5 - Senior Officer of Issuer
Direct Ownership
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
-1,100,844 vol 		0
Filed 2024-06-05 11:02
Tx date 2024-06-04 		$FUSN
Fusion Pharmaceuticals Inc. 		Crowley, John Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition 		$-136,500
-6,500 vol
$21.00 each 		0
Filed 2024-03-12 15:33
Tx date 2022-02-01 		$FUSN
Fusion Pharmaceuticals Inc. 		Crowley, John Joseph
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+11,059 vol 		744,744
Filed 2024-03-12 15:33
Tx date 2022-02-01 		$FUSN
Fusion Pharmaceuticals Inc. 		Crowley, John Joseph
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+155,941 vol 		733,685
Filed 2024-01-05 12:10
Tx date 2024-01-04 		$FUSN
Fusion Pharmaceuticals Inc. 		Crowley, John Joseph
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Units
56 - Grant of rights
+63,700 vol 		63,700
Filed 2024-01-05 12:10
Tx date 2020-06-25 		$FUSN
Fusion Pharmaceuticals Inc. 		Crowley, John Joseph
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Units
00 - Opening Balance-Initial SEDI Report
Filed 2024-01-05 12:10
Tx date 2024-01-04 		$FUSN
Fusion Pharmaceuticals Inc. 		Crowley, John Joseph
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+106,100 vol 		933,844
Filed 2023-01-09 09:06
Tx date 2023-01-05 		$FUSN
Fusion Pharmaceuticals Inc. 		Crowley, John Joseph
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+250,000 vol 		827,744
Filed 2021-02-08 18:51
Tx date 2021-02-04 		$FUSN
Fusion Pharmaceuticals Inc. 		Crowley, John Joseph
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+138,000 vol 		577,744
Filed 2020-07-03 19:20
Tx date 2020-06-26 		$
Fusion Pharmaceuticals Inc. 		Crowley, John Joseph
5 - Senior Officer of Issuer
Direct Ownership
Options
36 - Conversion or exchange
+351,920 vol 		439,744
Filed 2020-07-03 19:19
Tx date 2020-06-26 		$
Fusion Pharmaceuticals Inc. 		Crowley, John Joseph
5 - Senior Officer of Issuer
Direct Ownership
Options
36 - Conversion or exchange
-351,920 vol 		0
Filed 2020-07-03 19:16
Tx date 2020-06-30 		$
Fusion Pharmaceuticals Inc. 		Crowley, John Joseph
5 - Senior Officer of Issuer
Direct Ownership
Options
36 - Conversion or exchange
-351,920 vol
Filed 2020-07-03 19:14
Tx date 2020-06-30 		$
Fusion Pharmaceuticals Inc. 		Crowley, John Joseph
5 - Senior Officer of Issuer
Direct Ownership
Options
36 - Conversion or exchange
+351,920 vol
Filed 2020-07-03 17:15
Tx date 2020-06-30 		$
Fusion Pharmaceuticals Inc. 		Crowley, John Joseph
5 - Senior Officer of Issuer
Direct Ownership
Options
36 - Conversion or exchange
+351,920 vol
Filed 2020-07-03 17:15
Tx date 2020-06-30 		$
Fusion Pharmaceuticals Inc. 		Crowley, John Joseph
5 - Senior Officer of Issuer
Direct Ownership
Options
36 - Conversion or exchange
+351,920 vol 		439,744
Filed 2020-07-03 17:13
Tx date 2020-06-30 		$
Fusion Pharmaceuticals Inc. 		Crowley, John Joseph
5 - Senior Officer of Issuer
Direct Ownership
Options
36 - Conversion or exchange
-351,920 vol
Filed 2020-07-03 17:13
Tx date 2020-06-30 		$
Fusion Pharmaceuticals Inc. 		Crowley, John Joseph
5 - Senior Officer of Issuer
Direct Ownership
Options
36 - Conversion or exchange
-351,920 vol 		0
Filed 2020-07-03 17:10
Tx date 2020-06-30 		$
Fusion Pharmaceuticals Inc. 		Crowley, John Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$110,500
+6,500 vol
$17.00 each 		6,500
Filed 2020-07-03 17:09
Tx date 2020-06-25 		$
Fusion Pharmaceuticals Inc. 		Crowley, John Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2020-07-03 17:07
Tx date 2020-06-25 		$
Fusion Pharmaceuticals Inc. 		Crowley, John Joseph
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		87,824
Filed 2020-07-03 17:06
Tx date 2020-06-25 		$
Fusion Pharmaceuticals Inc. 		Crowley, John Joseph
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		351,920